G. Jeyanthi

AN ANALYSIS AND SIGNIFICANCE OF IMMUNOHISTOCHEMISTRY ER, PR AND HER2 TESTING FOR BREAST MALIGNANCY IN A TERTIARY CARE CENTER

2020 · Zenodo (CERN European Organization for Nuclear Research)

<p><strong>Background</strong>: A significant development in the Breast malignancy, the expression of Hormone receptors in the tumor cells for the management and prognosis.</p>\n\n<p><strong>Aim of Study : </strong>This study was<strong> </strong>conducted to correlate Immunohistochemical expression of markers such as …